S. Meyer et al., Autonomic and cardiovascular dysfunction in acute cerebral ischemia: Background and study purpose, AKT NEUROL, 28(4), 2001, pp. 170-175
Background and study purpose: Autonomic dysfunction is a common complicatio
n of cerebrovascular disease. The aim of this study was to investigate the
activity of the sympathetic nervous system, and cardiovascular system in ac
ute cerebral ischemia. Patients and methods: 55 patients with cerebral isch
emia (onset of symptoms < 24 h prior to admission) were included into a pro
spective study (mean age 61.3 +/- 1.5). Neurologic score was assessed using
the Scandinavian Stroke Scale Score (SSSS). Cardiac output, mean transcran
ial flow velocity in the middle cerebral artery, systolic and diastolic blo
od pressure, and heart Fate were recorded. Plasma norepinephrine (NE) and e
pinephrine (E) concentrations were measured with high performance liquid ch
romatography (concentration in ng/l). Data was obtained during the first 5
days after stroke. Values are given as mean +/- standard error of the mean.
Results: Cerebral ischemia caused an increase in sympathetic function in t
he acute phase (NE: 523.1 +/- 60.0) with a significant spontaneous decrease
(NE on day 5: 399.1 +/- 47.7). The alterations in autonomic function were
paralleled by augmented cardiovascular parameters. Systolic and diastolic b
lood pressure, and heart rate showed a significant drop. Cardiac output, on
the contrary, exhibited a significant increase which was inversely correla
ted to initial values. The most significant correlations existed between NE
, E and systolic and diastolic blood pressure. Heart rate was predominantly
modulated via the adrenergic axis. In hemispheric ischemia, mean transcran
ial flow velocity was higher on the affected side. Conclusion: Our study sh
ows that cerebral ischemia in the acute post-ischemic phase is accompanied
by autonomic and cardiovascular dysfunction. The increase in cardiac output
is possibly due to a spontaneous drop in systemic afterload. We conclude t
hat plasma catecholamines are a feasible means in monitoring changes of car
dio-autonomic function in acute cerebral ischemia.